Pharmaceutical Science Committee gets name change
FDA's Advisory Committee for Pharmaceutical Science will now be known as the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology, the March 5 Federal Register announces. The new name is intended to more accurately describe the subject areas for which the committee is responsible. The full committee is tentatively scheduled to meet next in May...
You may also be interested in...
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.
As a freshman member on the US House Energy and Commerce Committee, former St. Jude Medical exec Rep. Angie Craig can help shape future health care, cybersecurity bills.